Related Experiment Videos
What targets have knockouts revealed in asthma?
1The Sackler Institute of Pulmonary Pharmacology, 5th Floor Hodgkin Building, Guy's Campus, King's College London, London SE1 1UL, UK. james.moffatt@kcl.ac.uk
Pharmacology & Therapeutics
|May 24, 2005
Summary
Genetic knockout studies in mice reveal insights into allergic airway inflammation and potential drug targets for asthma. This review compiles findings on individual gene deficiencies and their impact on asthma pathologies.
Area of Science:
- Immunology
- Pharmacology
- Genetics
Background:
- Allergic inflammatory airway diseases, such as asthma, are complex conditions.
- Mouse models are crucial for studying immune responses and identifying therapeutic targets.
Purpose of the Study:
- To review the impact of individual gene knockouts on asthma-like pathologies in mice.
- To compare knockout study findings with pharmacological interventions.
- To assess the utility of these studies in drug development.
Main Methods:
- Compilation and analysis of existing studies on gene-deficient mice.
- Comparison of genetic knockout data with pharmacological data.
- Literature review and expert opinion.
Main Results:
- Individual gene knockouts significantly influence the development of asthma-like symptoms in mice.
- Results from knockout studies offer insights into potential drug targets.
- There is variability in how well knockout models predict drug efficacy.
Conclusions:
- Genetic knockout studies in mice are valuable for understanding asthma pathogenesis.
- These studies aid in identifying and validating pharmacological targets for asthma.
- Careful consideration is needed when translating findings to drug development.